SEC Charges and Settlement
2018
The U.S. Securities and Exchange Commission (SEC) charged Theranos, Holmes, and former COO Ramesh Balwani with raising $700 million from investors through a fraud involving false or exaggerated claims about the accuracy of the company's blood-testing technology. Holmes settled the charges by paying a $500,000 fine, returning 18.9 million shares to the company, relinquishing her voting control of Theranos, and accepting a ten-year ban from serving as an officer or director of a public company.